Organigram Global Inc. (TSX:OGI)
Canada · Delayed Price · Currency is CAD | Market Cap | 263.53M -16.4% |
| Revenue (ttm) | 279.99M +4,362.0% |
| Net Income | 18.17M |
| EPS | 0.14 |
| Shares Out | 135.14M |
| PE Ratio | 14.33 |
| Forward PE | 15.92 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 90,897 |
| Average Volume | 295,898 |
| Open | 1.980 |
| Previous Close | 1.950 |
| Day's Range | 1.940 - 2.000 |
| 52-Week Range | 1.220 - 3.090 |
| Beta | 2.09 |
| RSI | 45.74 |
| Earnings Date | Feb 10, 2026 |
About Organigram Global
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O’ Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dr... [Read more]
Full Company ProfileFinancial Performance
Financial StatementsNews
Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (“Organigram” or the “Company”) today announced the expansion of its international product portfolio, with the launch of Edison and BOXHOT medical cann...
What's Going On With Organigram Global Stock Thursday?
Organigram Global Inc. (OGI) shares rose after a $65.2 million private placement investment from British American Tobacco's subsidiary. ... Full story available on Benzinga.com
Organigram (OGI) Gains on C$65.2M Investment from British American Tobacco
Organigram (OGI) Gains on C$65.2M Investment from British American Tobacco
Organigram gets C$65.2M BAT investment for Sanity
Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading global cannabis company, today announced that it has entered into a subscription a...
Organigram Bets Big On Europe With Sanity Group Takeover
Organigram stock surges after announcing proposed acquisition of Sanity Group, aiming to establish as global pure-play cannabis company. ... Full story available on Benzinga.com
Organigram (OGI) Acquires Sanity Group to Expand European Presence
Organigram (OGI) Acquires Sanity Group to Expand European Presence
Organigram to buy Berlin-based Sanity Group in €113.4M deal, expanding cannabis supply network
Organigram Global to buy Sanity Group for up to €227M, expanding European cannabis supply chain.
Organigram Announces Proposed Acquisition of Sanity Group, a Leading German Cannabis Company
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that it has entered into a d...
Organigram Reports Increasing Revenue And Net Income For Q1-2026
3 Top Canadian Marijuana Stocks To Buy Sell Or Hold In 2026
What is it about the cannabis industry that keeps investors searching for top marijuana stocks to buy? Cannabis started as one of the first waves of peace, love, and rebellion towards many cultural in...
Organigram Global Is Now A Strong Buy
Organigram is upgraded to Strong Buy despite Q1 revenue and EBITDA missing estimates, citing long-term value and strategic positioning. OGI trades at a low 7.8x CY26 projected EBITDA and 1.1x tangible...
Organigram Global Inc (OGI) Q1 2026 Earnings Call Highlights: Record Revenue Growth and ...
Organigram Global Inc (OGI) Q1 2026 Earnings Call Highlights: Record Revenue Growth and Strategic Innovations
Organigram Global Inc. (OGI:CA) Q1 2026 Earnings Call Transcript
Organigram Global Inc. (OGI:CA) Q1 2026 Earnings Call Transcript
Organigram Global (OGI) Reports Strong Q1 Revenue Growth
Organigram Global (OGI) Reports Strong Q1 Revenue Growth
Organigram (OGI) Reports Strong Q1 Growth and Expanding International Reach
Organigram (OGI) Reports Strong Q1 Growth and Expanding International Reach
Earnings Scheduled For February 10, 2026
Companies Reporting Before The Bell • Duke Energy (NYSE: DUK) is projected to report quarterly earnings at $1.50 per share on revenue of $7.61 billion. • Sequans Communications (NYSE: SQNS) is proje...
Organigram Reports First Quarter Fiscal 2026 Results
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share1, is pleased to announce its results for the fi...
Earnings Preview For OrganiGram Holdings
OrganiGram Holdings (NASDAQ: OGI) is gearing up to announce its quarterly earnings on Tuesday, 2026-02-10. Here's a quick overview of what investors should know before the release. Analysts are estim...
Organigram Global (OGI) Set to Announce Q1 Earnings
Organigram Global (OGI) Set to Announce Q1 Earnings
Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, announced today it will report earnings result...
Organigram (OGI) Expands Innovation Investment with Phylos Bioscience Partnership
Organigram (OGI) Expands Innovation Investment with Phylos Bioscience Partnership
Organigram Extends Innovation Investment with Phylos
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share1, today announced the expansion of its innovati...
Organigram: Premium Pivot Signals Further Margin Expansion
Organigram reported solid Q4 earnings, highlighted by achieving a record gross margin and issuing a net revenue guidance implying sustained double-digit organic growth. Quebec's recent vape launch cou...
3 Best Cannabis Stocks: Will They Fly High Again Post Trump Schedule III?
Cannabis stocks sold off this week following President Trump's Executive Order directing marijuana's reclassification to Schedule III for increased medical and cannabidiol research. The sharp selloff ...